About this trial
Excisional biopsies are commonly performed in the oral mucosa, and proper wound closure and hemostasis are critical for the success of the surgical procedure. Suturing remains the gold standard for closing surgical incisions; however, it has several drawbacks, including being time-consuming and requiring technical skill for proper placement. In addition, access to posterior areas of the oral cavity can be challenging. Suturing may also cause patient discomfort during needle penetration of tissues and can serve as a potential pathway for microbial contamination. Therefore, this randomized controlled clinical trial aims to evaluate one of the latest tissue adhesives from the cyanoacrylate group (PeriAcryl 90 HV) compared to conventional surgical sutures (Nylon 4-0) for wound closure following oral excisional biopsies. A total of 28 patients with oral fibroma will be randomly assigned to either the tissue adhesive group or the suture group (14 patients per group).
Eligibility criteria
Qualifiers
Lesion requires excisional biopsy.
Lesion size greater than 3 mm and less than 3 cm in
Disqualifiers
Pregnant or breastfeeding women.
Patients taking anticoagulant medications (blood thinners).
Patients with infectious diseases such as hepatitis, HIV, etc.
Patients taking immunosuppressants.
Trial design
Treatments tested in this trial
- Tissue adhesive (PeriAcryl 90 HV)
- Surgical suture (Nylon 4-0)